Massani Marco, Capovilla Giovanni, Ruffolo Cesare, Bonariol Roberta, Maccatrozzo Paola, Tuci Francesco, Battistella Giuseppe, Grazi Gian Luca, Bassi Nicolò
Department of Surgery, Regional Center for HPB Surgery, Regional Hospital of Treviso, I-31100 Treviso, Italy.
Department of Surgical, Oncological and Gastroenterological Sciences, Padova University Hospital, University of Padova, I-35128 Padova, Italy.
Mol Clin Oncol. 2017 Oct;7(4):529-538. doi: 10.3892/mco.2017.1358. Epub 2017 Aug 1.
The aim of the present study was to evaluate the risk factors for postoperative complications following liver resection for colorectal cancer liver metastases. Patients who underwent hepatic resection for colorectal cancer liver metastases were stratified according to chemotherapy administration and body mass index (BMI) to eliminate potential confounding factors. A univariate analysis was conducted to identify potential risk factors for postoperative complications following liver resection. Variables that exhibited a potential association were evaluated by multivariable logistic regression analysis to identify those independently associated with postoperative morbidity. Between January 2012 and March 2012, 100 patients underwent hepatic resection for liver metastases from colorectal carcinoma at the Treviso Regional Hospital (Treviso, Italy) and at the Regina Elena National Cancer Institute (Rome, Italy). Of the 100 patients, 61 received preoperative oxaliplatin- or irinotecan-based chemotherapy. A total of 25 the patients had a BMI of ≥28 kg/m. On univariate analysis, BMI ≥28 kg/m was found to be positively correlated with the presence of steatosis (P<0.01) and steatohepatitis (P<0.01). The administration of preoperative chemotherapy was correlated with the development of steatosis (P<0.01), steatohepatitis (P=0.02) and postoperative complications (P=0.03). Even following stratification for the use of preoperative chemotherapy, BMI ≥28 kg/m maintained its positive association with steatohepatitis. On multivariate analysis, steatohepatitis (P=0.005, HR=0.118, 95% CI: 0.027-0.518) and blood transfusions (P=0.001, HR=0.131, 95% CI: 0.038-0.452) were independently associated with postoperative complications. BMI ≥28 kg/m (P=0.004, HR=8.30, 95% CI: 2.39-28.7) and irinotecan treatment (P=0.016, HR=0.16, 95% CI: 0.037-0.711) were independent risk factors for steatohepatitis. In conclusion, steatohepatitis and perioperative blood transfusions were found to be the main determinant of postoperative complications following liver resection for colorectal liver metastases. Overweight patients may be more prone to the cytotoxic effects of irinotecan, harboring a higher risk of developing steatohepatitis.
本研究的目的是评估结直肠癌肝转移灶肝切除术后并发症的危险因素。对接受结直肠癌肝转移灶肝切除术的患者,根据化疗用药情况和体重指数(BMI)进行分层,以消除潜在的混杂因素。进行单因素分析以确定肝切除术后并发症的潜在危险因素。对显示有潜在关联的变量进行多变量逻辑回归分析,以确定那些与术后发病率独立相关的因素。2012年1月至2012年3月期间,100例患者在意大利特雷维索地区医院(特雷维索)和意大利 Regina Elena 国家癌症研究所(罗马)接受了结直肠癌肝转移灶的肝切除术。在这100例患者中,61例接受了术前基于奥沙利铂或伊立替康的化疗。共有25例患者的BMI≥28kg/m²。单因素分析发现,BMI≥28kg/m²与脂肪变性(P<0.01)和脂肪性肝炎(P<0.01)的存在呈正相关。术前化疗的应用与脂肪变性(P<0.01)、脂肪性肝炎(P=0.02)和术后并发症(P=0.03)的发生相关。即使在对术前化疗的使用进行分层后,BMI≥28kg/m²与脂肪性肝炎仍保持正相关。多变量分析显示,脂肪性肝炎(P=0.005,HR=0.118,95%CI:0.027 - 0.518)和输血(P=0.001,HR=0.131,95%CI:0.038 - 0.452)与术后并发症独立相关。BMI≥28kg/m²(P=0.004,HR=8.30,95%CI:2.39 - 28.7)和伊立替康治疗(P=0.016,HR=0.16,95%CI:0.037 - 0.711)是脂肪性肝炎的独立危险因素。总之,脂肪性肝炎和围手术期输血是结直肠癌肝转移灶肝切除术后并发症的主要决定因素。超重患者可能更容易受到伊立替康的细胞毒性作用影响,发生脂肪性肝炎的风险更高。